BR112012011262A2 - sistemas e métodos para detectar a presença de um estado biológico usando aglomeração - Google Patents

sistemas e métodos para detectar a presença de um estado biológico usando aglomeração

Info

Publication number
BR112012011262A2
BR112012011262A2 BR112012011262A BR112012011262A BR112012011262A2 BR 112012011262 A2 BR112012011262 A2 BR 112012011262A2 BR 112012011262 A BR112012011262 A BR 112012011262A BR 112012011262 A BR112012011262 A BR 112012011262A BR 112012011262 A2 BR112012011262 A2 BR 112012011262A2
Authority
BR
Brazil
Prior art keywords
genetic element
input values
samples
input
agglomeration
Prior art date
Application number
BR112012011262A
Other languages
English (en)
Portuguese (pt)
Inventor
Arevalo Reyes Antonio
Alan Gustafson Erik
Lu Jiuliu
Steven Riley John
Wang Zihua
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Publication of BR112012011262A2 publication Critical patent/BR112012011262A2/pt

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30Unsupervised data analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112012011262A 2009-11-13 2010-11-12 sistemas e métodos para detectar a presença de um estado biológico usando aglomeração BR112012011262A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26114709P 2009-11-13 2009-11-13
PCT/US2010/056455 WO2011060222A2 (en) 2009-11-13 2010-11-12 Systems and methods for detecting the presence of a biological status using clustering

Publications (1)

Publication Number Publication Date
BR112012011262A2 true BR112012011262A2 (pt) 2019-09-24

Family

ID=43806873

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011262A BR112012011262A2 (pt) 2009-11-13 2010-11-12 sistemas e métodos para detectar a presença de um estado biológico usando aglomeração

Country Status (8)

Country Link
US (3) US8442924B2 (https=)
EP (1) EP2499591A2 (https=)
JP (2) JP5907880B2 (https=)
KR (1) KR20120101065A (https=)
CN (1) CN102713919B (https=)
BR (1) BR112012011262A2 (https=)
RU (1) RU2012124051A (https=)
WO (1) WO2011060222A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010076013A1 (de) * 2008-12-30 2010-07-08 Qiagen Gmbh Verfahren zum nachweis methicillin-resistenter staphylococcus aureus (mrsa)-stämme
JP5907880B2 (ja) 2009-11-13 2016-04-26 ベックマン コールター, インコーポレイテッド クラスタリングを用いて生物学的持続状態の存在を検出するためのシステムおよび方法
EP2617836A1 (en) * 2012-01-23 2013-07-24 Steffen Mergemeier Method for detecting a methicillin resistant coagulase positive Staphylococcus aureus strain
EP2887245A1 (en) * 2013-12-20 2015-06-24 Dassault Systèmes A computer-implemented method for designing a biological model
WO2022260129A1 (ja) * 2021-06-09 2022-12-15 国立大学法人京都大学 情報処理装置、情報処理方法、及びプログラム

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US6335184B1 (en) * 1993-07-23 2002-01-01 Bio-Rad Laboratories, Inc. Linked linear amplification of nucleic acids
US5702895A (en) 1995-01-19 1997-12-30 Wakunaga Seiyaku Kabushiki Kaisha Method and kit for detecting methicillin-resistant Staphylococcus aureus
JP3957338B2 (ja) * 1996-02-23 2007-08-15 株式会社カイノス 診断薬
US6358519B1 (en) * 1998-02-16 2002-03-19 Ruth S. Waterman Germ-resistant communication and data transfer/entry products
JP2003523175A (ja) * 1999-08-04 2003-08-05 ファルマシア・アンド・アップジョン・カンパニー スタフィロコッカスアウレウスUDP−N−アセチルエノールピルビルグルコサミン=リダクターゼ(S.aureusMurB)の結晶化および構造決定
ES2281520T3 (es) 2001-03-15 2007-10-01 Jacques Schrenzel Deteccion de staphylococcus aureus resistente a meticilina (sarm).
US20030014420A1 (en) * 2001-04-20 2003-01-16 Jessee Charles B. Method and system for data analysis
FR2844807B1 (fr) * 2002-09-23 2005-11-11 Rambach Alain Procede de detection de microorganismes resistants a la meticilline
EP1603674B1 (en) * 2003-02-05 2016-01-06 Iquum, Inc. Sample processing
EP1529847B1 (en) 2003-11-07 2006-04-05 Federal Rep. of Germany repr. by the Ministry of Health & Soc. Security, the latter repr. by the Pres. of the Robert Koch Ins. Method for detecting methicillin resistant Staphylococcus aureus (MRSA)
EP1541696A1 (en) 2003-12-09 2005-06-15 Institut Pasteur A DNA macro-array for staphylococcus aureus identification and typing
EP1776458A2 (en) 2004-07-30 2007-04-25 Agencourt Bioscience Corporation Methods of isolating nucleic acids using multifunctional group-coated solid phase carriers
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
GB0504537D0 (en) * 2005-03-04 2005-04-13 Blaze Venture Technologies Ltd Method and device for bacterial sampling
US20070196820A1 (en) * 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US7838221B2 (en) * 2005-10-11 2010-11-23 Geneohm Sciences, Inc. Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA)
AU2007249812B2 (en) 2006-05-12 2013-08-15 Cepheid DNA recombination junction detection
JP5183635B2 (ja) * 2006-10-18 2013-04-17 ビオメリュー Pvl産生黄色ブドウ球菌のインビトロにおける診断方法
WO2008129428A2 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
US7888075B2 (en) * 2007-07-31 2011-02-15 Quest Diagnostics Investments Incorporated Detection of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in biological samples
US8229678B2 (en) * 2008-07-25 2012-07-24 Beckman Coulter, Inc. Methods and systems for transforming particle data
US8000940B2 (en) * 2008-10-08 2011-08-16 Beckman Coulter, Inc. Shape parameter for hematology instruments
US8154273B2 (en) * 2008-10-10 2012-04-10 Beckman Coulter, Inc. Detecting and handling coincidence in particle analysis
US8581927B2 (en) * 2008-11-04 2013-11-12 Beckman Coulter, Inc. Multidimensional particle analysis data cluster reconstruction
PL2356465T3 (pl) * 2008-11-13 2015-04-30 Beckman Coulter Inc Sposób korekcji interferencji cząsteczkowej przy oznaczaniu hemoglobiny
JP5907880B2 (ja) 2009-11-13 2016-04-26 ベックマン コールター, インコーポレイテッド クラスタリングを用いて生物学的持続状態の存在を検出するためのシステムおよび方法

Also Published As

Publication number Publication date
WO2011060222A9 (en) 2011-07-14
US20130196334A1 (en) 2013-08-01
JP2013510579A (ja) 2013-03-28
US20110131159A1 (en) 2011-06-02
EP2499591A2 (en) 2012-09-19
US8442924B2 (en) 2013-05-14
RU2012124051A (ru) 2013-12-20
CN102713919A (zh) 2012-10-03
CN102713919B (zh) 2016-07-06
WO2011060222A2 (en) 2011-05-19
US20170140096A1 (en) 2017-05-18
JP5907880B2 (ja) 2016-04-26
JP2015165413A (ja) 2015-09-17
KR20120101065A (ko) 2012-09-12
US9519751B2 (en) 2016-12-13

Similar Documents

Publication Publication Date Title
Hardwick et al. Single-nuclei isoform RNA sequencing unlocks barcoded exon connectivity in frozen brain tissue
Krebs et al. Genome-wide single-molecule footprinting reveals high RNA polymerase II turnover at paused promoters
Murakawa et al. Enhanced identification of transcriptional enhancers provides mechanistic insights into diseases
Price et al. Different measures of “genome-wide” DNA methylation exhibit unique properties in placental and somatic tissues
Wang et al. Differential expression of plasma miR-146a in sepsis patients compared with non-sepsis-SIRS patients
Sethi et al. Clinical advances in molecular biomarkers for cancer diagnosis and therapy
Vounou et al. Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease
Rastin et al. Complexity in genetic epilepsies: a comprehensive review
Sánchez et al. Minimal residual disease monitoring with next-generation sequencing methodologies in hematological malignancies
MX2016016904A (es) Analisis de secuencias de acidos nucleicos.
Bressan et al. The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism
Demeler et al. Advances in laboratory diagnosis of parasitic infections of sheep
GB2568608A (en) Personalized genetic testing
MX2019002093A (es) Métodos para la detección de cambios de copia genómica en muestras de adn.
Ishak et al. Diagnostic, prognostic, and therapeutic value of droplet digital PCR (ddPCR) in COVID-19 patients: a systematic review
MY170164A (en) Aptamer-based multiplexed assays
BR112015022322A2 (pt) sistemas e métodos para detecção de células com o uso de partículas de transdução projetadas
Ohyashiki et al. Downregulation of plasma miR-215 in chronic myeloid leukemia patients with successful discontinuation of imatinib
BR112012011262A2 (pt) sistemas e métodos para detectar a presença de um estado biológico usando aglomeração
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
WO2009017879A3 (en) Image portion identification methods, image parsing methods, image parsing systems, and articles of manufacture
de Oliveira et al. Can global DNA methylation be influenced by polymorphisms in genes involved in epigenetic mechanisms? A review
Ren et al. Parallel reporter assays identify altered regulatory role of rs684232 in leading to prostate cancer predisposition
BR112016003058A2 (pt) composições e métodos para análise multiplex de ácidos nucleicos nras e braf
WO2015038987A3 (en) System and method for whole-animal high-throughput compound screening

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.